Table 2 The laboratoury findings of CCHF patients in the study

Alkaline phosphatase (ALP)

35–270 U/L

Albumin

3.5–5 mg/dL

Alanine aminotransferase (ALT)

7–35 U/L

Aspartate aminotransferase (AST)

10–38 U/L

Blood uremia nitrogen (BUN)

8–23 mg/dL

Direct bilirubin

0.01–0.3 mg/dL

Gamma glutamyl transferase (GGT)

5–61 U/L

Creatine kinase (CK)

0–170 U/L

C-reactive protein (CRP)

0–5 mg/L

Calcium

8.8–10.6 mg/dL

Creatinine

0.6–1.09 mg/dL

Lactate dehydrogenase (LDH)

135–214 U/L

Total bilirubin

0.01–1.2 mg/dL

Uric acid

3.5–7.2 mg/dL

White blood cell

4.5–10 10³/µL

Neutrophile

2–8.9 10³/µL

Lymphocyte

1. 3–3.35 10³/µL

Monocyte

0.25–0.85 10³/µL

Red blood cell

4.5–5.9 10⁶/mL

Red cell distribution width (RDW)

12.1–14.3 %

Hemoglobin

13.5–17.5 gr/dl

Haematocrit

41–53 %

Platelet

150–400 10³/μL

Platelet distribution width (PDW)

10.1–16.1 %

Mean platelet volume (MPV)

9.1–11.9 fL

Partial thromboplastin time (%PTT)

70–120 %

Partial thromboplastin time (PTT)

10.1–14.9 s

International normalization ratio (INR)

0.8–1.2

Activated partial thromboplastin time (APTT)

23–35 s

D-dimer

0–0.5 mg/dL

Fibrinogen

202–430 mg/dL

Ferritin

20–400 µg/L

Procalcitonin

0–0.05 µg/L

Sedimentation

0–20 mm/h